Citations

Citations to this article as recorded by  

• Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice
  Hae Young Kim, Seung Hyun Cho, Jong Keon Jang, Bohyun Kim, Chul-min Lee, Joon Seok Lim, Sung Kyoung Moon, Soon Nam Oh, Nieun Seo, Seong Ho Park
  Korean Journal of Radiology.2024; 25(4): 351.     CrossRef
• Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches
  Gizem Kaval, Merve Gulbiz Dagoglu Kartal, Sena Azamat, Eda Cingoz, Gokhan Ertas, Sule Karaman, Basak Kurtuldu, Metin Keskin, Neslihan Berker, Senem Karabulut, Ethem Nezih Oral, Nergiz Dagoglu Sakin
  Pathology and Oncology Research.2024;[Epub]     CrossRef
• Regressionsgrading gastrointestinaler Tumoren
  Doreen Maria Gisder, Andrea Tannapfel, Iris Tischoff
  Die Gastroenterologie.2024; 19(3): 234.     CrossRef
• Rectal Cancer Survival for Residual Carcinoma In Situ Vs. Pathologic Complete Response After Neoadjuvant Therapy
  Nathan M. Kohrman, Jordan R. Wlodarczyk, Li Ding, Nicholas P. McAndrew, Sandra D. Algaze, Kyle G. Cologne, Sang W. Lee, Sarah E Koller
  Diseases of the Colon & Rectum.2024;[Epub]     CrossRef
• Predictive value of flexible proctosigmoidoscopy and laboratory findings for complete clinical responses after neoadjuvant chemoradiotherapy in patients with locally advanced primary rectal cancer: a retrospective cohort study
  Alireza Hadizadeh, Hamed Kazemi-Khaledi, Mohammad-Sadegh Fazeli, Seyed-Mohsen Ahmadi-Tafti, Amir Keshvari, Reza Akbari-Asbagh, Mohammad-Reza Keramati, Alireza Kazemeini, Amir-Reza Fazeli, Behnam Behboudi, Mohammadamin Parsaei
  International Journal of Colorectal Disease.2024;[Epub]     CrossRef
• Are the tumor microenvironment characteristics of pretreatment biopsy specimens of colorectal cancer really effectively predict the efficacy of neoadjuvant therapy: A retrospective multicenter study
  Bingbing Li, Longjiao Chen, Yichun Huang, Meng Wu, Weilan Fang, Xin Zou, Yihong Zheng, Qiuxiang Xiao
  Medicine.2024; 103(35): e39429.     CrossRef
• Outcomes of rectal cancer treatment in rural Australia and New Zealand: analysis of the bowel cancer outcomes registry
  Ishmam Murshed, Tessa L. Dinger, Duveke P. E. de Gaay Fortman, Luke Traeger, Sergei Bedrikovetski, Andrew Hunter, Hidde M. Kroon, Tarik Sammour
  ANZ Journal of Surgery.2024; 94(10): 1823.     CrossRef
• Relationship Between Neoadjuvant Chemoradiotherapy Response and Mesorectum Volume in Rectum Cancer
  Ramazan Saygın Kerimoğlu, Ebru Esen, Mustafa Saraçoğlu, İbrahim Babalıoğlu, Bekir Turgut, İlknur Küçükosmanoğlu, Osman Doğru
  Acta Haematologica Oncologica Turcica.2024; : 44.     CrossRef
• Molecular Mechanism of Radioresponsiveness in Colorectal Cancer: A Systematic Review
  Matthew Lau, Md Islam Khan, Helen Law
  Genes.2024; 15(10): 1257.     CrossRef
• Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy
  Jun-Eul Hwang, Sung-Sun Kim, Hyun-Jin Bang, Hyeon-Jong Kim, Hyun-Jeong Shim, Woo-Kyun Bae, Ik-Joo Chung, Eun-Gene Sun, Taebum Lee, Chan-Young Ock, Jeong-Seok Nam, Sang-Hee Cho
  Cancers.2024; 16(19): 3353.     CrossRef
• A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors
  Kevin Chih-Yang Huang, Chia-Ying Lai, Wei-Ze Hung, Hsin-Yu Chang, Pei-Chun Lin, Shu-Fen Chiang, Tao-Wei Ke, Ji-An Liang, An-Cheng Shiau, Pei-Chen Yang, William Tzu-Liang Chen, K.S. Clifford Chao
  Cancer Immunology Research.2023; 11(1): 123.     CrossRef
• Does Pathological Complete Response after Neoadjuvant Therapy Influence Postoperative Morbidity in Rectal Cancer after Transanal Total Mesorectal Excision?
  Martin Svoboda, Vladimír Procházka, Tomáš Grolich, Tomáš Pavlík, Monika Mazalová, Zdeněk Kala
  Journal of Gastrointestinal Cancer.2023; 54(2): 528.     CrossRef
• MRI‐Based Artificial Intelligence in Rectal Cancer
  Chinting Wong, Yu Fu, Mingyang Li, Shengnan Mu, Xiaotong Chu, Jiahui Fu, Chenghe Lin, Huimao Zhang
  Journal of Magnetic Resonance Imaging.2023; 57(1): 45.     CrossRef
• Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non‐responders' tumor tissue
  Tamara Babic, Vasiliki Lygirou, Jovana Rosic, Marko Miladinov, Aleksandra Djikic Rom, Eirini Baira, Rafael Stroggilos, Eftychia Pappa, Jerome Zoidakis, Zoran Krivokapic, Aleksandra Nikolic
  PROTEOMICS – Clinical Applications.2023;[Epub]     CrossRef
• Comparison of the diagnostic performance of changes in signal intensity and volume from multiparametric MRI for assessing response of rectal cancer to neoadjuvant chemoradiotherapy
  Zhengwu Tan, Lan Cheng, Lingling Xie, Lan Zhang, Zhenyu Lin, Ping Han, Xin Li
  Asia-Pacific Journal of Clinical Oncology.2023; 19(3): 327.     CrossRef
• Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy
  Emese Sarolta Bádon, Lívia Beke, Attila Mokánszki, Csilla András, Gábor Méhes
  International Journal of Molecular Sciences.2023; 24(3): 2581.     CrossRef
• Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
  Hyun Jin Bang, Hyun Jeong Shim, Jun Eul Hwang, Woo Kyun Bae, Ik Joo Chung, Sang Hee Cho
  Chonnam Medical Journal.2023; 59(1): 76.     CrossRef
• The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma
  Topias Karjula, Niko Kemi, Anne Niskakangas, Olli Mustonen, Iiris Puro, Vesa-Matti Pohjanen, Teijo Kuopio, Hanna Elomaa, Maarit Ahtiainen, Jukka-Pekka Mecklin, Toni T. Seppälä, Erkki-Ville Wirta, Eero Sihvo, Juha P. Väyrynen, Fredrik Yannopoulos, Olli Hel
  European Journal of Surgical Oncology.2023; 49(7): 1298.     CrossRef
• An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
  Supparerk Laohawiriyakamol, Wongsakorn Chaochankit, Worawit Wanichsuwan, Kanet Kanjanapradit, Teeranan Laohawiriyakamol
  Annals of Coloproctology.2023; 39(1): 59.     CrossRef
• Deep learning of endoscopic features for the assessment of neoadjuvant therapy response in locally advanced rectal cancer
  Anqi Wang, Jieli Zhou, Gang Wang, Beibei Zhang, Hongyi Xin, Haiyang Zhou
  Asian Journal of Surgery.2023; 46(9): 3568.     CrossRef
• Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
  Jingjing Wu, Mingzhe Huang, Yuanhui Wu, Yisong Hong, Linbin Cai, Rongzhao He, Yanxin Luo, Puning Wang, Meijin Huang, Jinxin Lin
  Journal of Cancer Research and Clinical Oncology.2023; 149(11): 8897.     CrossRef
• A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study
  Yihan Wu, Xiaohua Liu, Fang Liu, Yi Li, Xiaomin Xiong, Hao Sun, Bo Lin, Yu Li, Bo Xu
  PeerJ.2023; 11: e15408.     CrossRef
• Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients
  Caterina Foppa, Annalisa Maroli, Antonio Luberto, Carlotta La Raja, Paola Spaggiari, Cristiana Bonifacio, Stefano De Zanet, Marco Montorsi, Salvatore Piscuoglio, Luigi Maria Terracciano, Armando Santoro, Antonino Spinelli
  Cancers.2023; 15(14): 3750.     CrossRef
• Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
  I-Li Lai, Jeng-Fu You, Wen-Sy Tsai, Yu-Jen Hsu, Yih-Jong Chern, Ming-Ying Wu
  World Journal of Surgical Oncology.2023;[Epub]     CrossRef
• Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis
  De-xing Zeng, Zhou Yang, Ling Tan, Meng-ni Ran, Zi-lin Liu, Jiang-wei Xiao
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Clinical predictors of rectal cancer response after neo-adjuvant (Chemo)Radiotherapy in Australia and New Zealand: Analysis of the Bi-National Colorectal Cancer Audit (BCCA)
  Jianliang Liu, Justin Y.T. Lee, Sergei Bedrikovetski, Luke Traeger, James W. Moore, Joanne L. Perry, Hidde M. Kroon, Tarik Sammour
  European Journal of Surgical Oncology.2023; 49(11): 107070.     CrossRef
• Pancreatic ductal adenocarcinoma complete regression after preoperative chemotherapy: Surgical results in a small series
  Domenico Pinelli, Andrea Micalef, Barbara Merelli, Rosangela Trezzi, Annalisa Amaduzzi, Stefano Agnesi, Michela Guizzetti, Stefania Camagni, Veronica Fedele, Michele Colledan
  Cancer Treatment and Research Communications.2023; 37: 100770.     CrossRef
• The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0
  Yujun Cui, Xinzhi Liu, Shuai Li, Hongzhi Wang, Yirong Xiang, Yangzi Zhang, Maxiaowei Song, Jianhao Geng, Zhiyan Liu, Huajing Teng, Xianggao Zhu, Yong Cai, Yongheng Li, Weihu Wang
  Clinical and Translational Oncology.2023; 26(4): 1012.     CrossRef
• Grading der Tumorregression gastrointestinaler Karzinome nach neoadjuvanter Therapie
  Drolaiz Liu, Rupert Langer
  Der Pathologe.2022; 43(1): 51.     CrossRef
• Deeper sections reveal residual tumor cells in rectal cancer specimens diagnosed with pathological complete response following neoadjuvant treatment
  Lasse Slumstrup, Susanne Eiholm, Astrid Louise Bjørn Bennedsen, Dea Natalie Munch Jepsen, Ismail Gögenur, Anne-Marie Kanstrup Fiehn
  Virchows Archiv.2022; 480(5): 1041.     CrossRef
• MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy
  Jaeseung Shin, Nieun Seo, Song-Ee Baek, Nak-Hoon Son, Joon Seok Lim, Nam Kyu Kim, Woong Sub Koom, Sungwon Kim
  Radiology.2022; 303(2): 351.     CrossRef
• Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer
  Laureline Lamy, Jacques Thomas, Agnès Leroux, Jean-François Bisson, Kari Myren, Aslak Godal, Gry Stensrud, Lina Bezdetnaya
  Biomedicines.2022; 10(3): 548.     CrossRef
• High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates
  Serdar Karakaya, İbrahim Karadağ, Mehmet Emin Yılmaz, Ömür Berna Çakmak Öksüzoğlu
  Cureus.2022;[Epub]     CrossRef
• Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
  Dea Natalie Munch Jepsen, Henrik Høeg, Jeppe Thagaard, Julie Sparholt Walbech, Ismail Gögenur, Anne-Marie Kanstrup Fiehn
  Journal of Pathology Informatics.2022; 13: 100152.     CrossRef
• The reduction of 18F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression
  Fengpeng Wu, Xiaoxiao Zhang, Congrong Yang, Kanghua Wang, Linlin Xiao, Chaoxi Zhou, Xinming Zhao, Guiying Wang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Reduced field-of-view versus full field-of-view diffusion-weighted imaging for the evaluation of complete response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
  Siwon Jang, Jeong Min Lee, Jeong Hee Yoon, Jae Seok Bae
  Abdominal Radiology.2021; 46(4): 1468.     CrossRef
• Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer
  Peige Zhou, Paolo Goffredo, Timothy Ginader, Dakota Thompson, Jennifer Hrabe, Irena Gribovskaja‐Rupp, Muneera Kapadia, Imran Hassan
  Journal of Surgical Oncology.2021; 123(1): 278.     CrossRef
• Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation
  Jesse Fischer, Tim W. Eglinton, Frank A. Frizelle
  ANZ Journal of Surgery.2021; 91(6): 1190.     CrossRef
• Can the mesorectal fat tissue volume be used as a predictive factor in foreseeing the response to neoadjuvant chemoradiotherapy in rectum cancer? A CT-based preliminary study
  Okan Dilek, Huseyin Akkaya, Cenk Parlatan, Tolga Koseci, Zeynel Abidin Tas, Gökhan Soker, Bozkurt Gulek
  Abdominal Radiology.2021; 46(6): 2415.     CrossRef
• Pathological response post neoadjuvant therapy for locally advanced rectal cancer is an independent predictor of survival
  Jason On, Joanna Shim, Craig Mackay, Graeme Murray, Leslie Samuel, Craig Parnaby, George Ramsay
  Colorectal Disease.2021; 23(6): 1326.     CrossRef
• Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review
  K. Wilson, M. Flood, V. Narasimhan, T. Pham, S. Warrier, R. Ramsay, M. Michael, A. Heriot
  European Journal of Surgical Oncology.2021; 47(8): 1862.     CrossRef
• Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience
  Paola Germani, Francesca Di Candido, Daniel Léonard, Dajana Cuicchi, Ugo Elmore, Marco Ettore Allaix, Vittoria Pia Barbieri, Laura D’Allens, Seraina Faes, Marika Milani, Damiano Caputo, Carmen Martinez, Jan Grosek, Valerio Caracino, Niki Christou, Sapho X
  Updates in Surgery.2021; 73(5): 1795.     CrossRef
• The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
  Yanting Liang, Yaxi Zhu, Huan Lin, Shenyan Zhang, Suyun Li, Yanqi Huang, Chen Liu, Jinrong Qu, Changhong Liang, Ke Zhao, Zhenhui Li, Zaiyi Liu
  BMC Cancer.2021;[Epub]     CrossRef
• Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?
  Yuho Ono, Justin M.M. Cates, Raul S. Gonzalez
  Pathology - Research and Practice.2021; 226: 153608.     CrossRef
• A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
  Zhengfa Xue, Shuxin Yang, Yun Luo, Hao Cai, Ming He, Youping Ding, Lei Lei, Wei Peng, Guini Hong, You Guo
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
  Tomoyuki Momma, Hirokazu Okayama, Yasuyuki Kanke, Satoshi Fukai, Hisashi Onozawa, Shotaro Fujita, Wataru Sakamoto, Motonobu Saito, Shinji Ohki, Koji Kono
  Cancers.2021; 13(18): 4642.     CrossRef
• Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey
  Maria Westerhoff, Marek Osecky, Rupert Langer
  Modern Pathology.2020; 33(4): 676.     CrossRef
• Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer
  Toshiki Mukai, Keisuke Uehara, Toshisada Aiba, Atsushi Ogura, Toyonori Tsuzuki, Aya Tanaka, Masanori Sando, Noriyuki Ohara, Yusuke Sato, Norifumi Hattori, Goro Nakayama, Yasuhiro Kodera, Masato Nagino
  Surgery Today.2020; 50(8): 912.     CrossRef
• The Effect of Lymph Nodes’ Histologic Response on Survival Outcomes in Moroccan Patients with Rectal Cancer
  Ihsane El Otmani, Fatima El Agy, Mohammed El Abkari, Karim Ibn Majdoub Hassani, Khalid Mazaz, El Bachir Benjelloun, Khalid Ait Taleb, Touria Bouhafa, Zineb Benbrahim, Sidi Adil Ibrahimi, Laila Chbani
  International Journal of Surgical Oncology.2020; 2020: 1.     CrossRef
• Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus
  Flávio Roberto Takeda, Francisco Tustumi, Carlos de Almeida Obregon, Gustavo Gonçalves Yogolare, Yasmin Peres Navarro, Vanderlei Segatelli, Rubens Antonio Aissar Sallum, Ulysses Ribeiro Junior, Ivan Cecconello
  Annals of Surgical Oncology.2020; 27(4): 1241.     CrossRef
• Standardized Pathology Report for Colorectal Cancer, 2nd Edition
  Baek-hui Kim, Joon Mee Kim, Gyeong Hoon Kang, Hee Jin Chang, Dong Wook Kang, Jung Ho Kim, Jeong Mo Bae, An Na Seo, Ho Sung Park, Yun Kyung Kang, Kyung-Hwa Lee, Mee Yon Cho, In-Gu Do, Hye Seung Lee, Hee Kyung Chang, Do Youn Park, Hyo Jeong Kang, Jin Hee So
  Journal of Pathology and Translational Medicine.2020; 54(1): 1.     CrossRef
• Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer
  Jason K. Douglas, Rose E. Callahan, Zachary A. Hothem, Craig S. Cousineau, Samer Kawak, Bryan J. Thibodeau, Shelli Bergeron, Wei Li, Claire E. Peeples, Harry J. Wasvary
  Molecular & Cellular Oncology.2020; 7(3): 1716618.     CrossRef
• 53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer
  Ai Huang, Yong Xiao, Chunfen Peng, Tao Liu, Zhenyu Lin, Qin Yang, Tao Zhang, Jun Liu, Hong Ma
  Strahlentherapie und Onkologie.2020; 196(5): 465.     CrossRef
• Predictors of pathological response and clinical outcome following chemoradiation for locally advanced rectal cancer — a systematic review
  Erica Amaral, Maria Bernardes, Sara Ribeiro, Beatriz Rosa, Ana Pereira, Sandra F. Martins
  Journal of Coloproctology.2020; 40(03): 278.     CrossRef
• The effect of radiotherapy on rectal cancer: a histopathological appraisal and prognostic indicators
  Mohammad AlQudah, Emil Salmo, Najib Haboubi
  Radiation Oncology Journal.2020; 38(2): 77.     CrossRef
• Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial
  Mahdi Aghili, Nastaran Khalili, Neda Khalili, Mohammad Babaei, Farshid Farhan, Peiman Haddad, Samaneh Salarvand, Amir Keshvari, Mohammad Sadegh Fazeli, Negin Mohammadi, Reza Ghalehtaki
  Radiation Oncology Journal.2020; 38(2): 119.     CrossRef
• Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study
  Bianca Petresc, Andrei Lebovici, Cosmin Caraiani, Diana Sorina Feier, Florin Graur, Mircea Marian Buruian
  Cancers.2020; 12(7): 1894.     CrossRef

• Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

  
  Siyi Lu, Zhenzhen Liu, Xin Zhou, Bingyan Wang, Fei Li, Yanpeng Ma, Wendong Wang, Junren Ma, Yuxia Wang, Hao Wang, Wei Fu
  Cancer Management and Research.2020; Volume 12: 8555.     CrossRef
• Staging of Locally Advanced Rectal Cancer Beyond TME
  Deborah S. Keller
  Clinics in Colon and Rectal Surgery.2020; 33(05): 258.     CrossRef
• Tumor Regression in Lymph Node Metastases of Esophageal Adenocarcinomas after Neoadjuvant Therapy
  Marek Osecky, Dino Kröll, Marcus Feith, Daniel Reim, Bastian Dislich, Karen Becker, Rupert Langer
  Gastrointestinal Disorders.2020; 2(4): 397.     CrossRef
• Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer
  Chinock Cheong, Jun Sang Shin, Kwang Wook Suh
  World Journal of Gastroenterology.2020; 26(44): 7022.     CrossRef
• MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in Radiation Resistance
  Frederike Butz, Ann-Kathrin Eichelmann, George C. Mayne, Tingting Wang, Isabell Bastian, Karen Chiam, Shashikanth Marri, Pamela J. Sykes, Bas P. Wijnhoven, Eelke Toxopeus, Michael Z. Michael, Christos S. Karapetis, Richard Hummel, David I. Watson, Damian
  International Journal of Molecular Sciences.2020; 21(23): 8898.     CrossRef
• Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer
  Heyu Song, Jiping Zeng, Shrabasti Roychoudhury, Pranjal Biswas, Bhopal Mohapatra, Sutapa Ray, Kayvon Dowlatshahi, Jing Wang, Vimla Band, Geoffrey Talmon, Kishor K. Bhakat
  Molecular Cancer Therapeutics.2020; 19(1): 258.     CrossRef
• Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy
  Jung Wook Huh, Hee Cheol Kim, Seok Hyung Kim, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Chul Park, Doo Ho Choi, Joon Oh Park, Young Suk Park, Ho-Kyung Chun
  Surgery.2019; 165(3): 579.     CrossRef
• Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial
  Johan Erlandsson, Ester Lörinc, Madelene Ahlberg, David Pettersson, Torbjörn Holm, Bengt Glimelius, Anna Martling
  Radiotherapy and Oncology.2019; 135: 178.     CrossRef
• Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy
  Kwang-Seop Song, Dong Woon Lee, Bun Kim, Bo Yun Hur, Min Jung Kim, Min Ju Kim, Chang Won Hong, Sung Chan Park, Hyoung-Chul Park, Dae Kyung Sohn, Byung Chang Kim, Kyung Su Han, Jae Hwan Oh
  Scientific Reports.2019;[Epub]     CrossRef
• A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma
  Zahra Kassam, Kyle Burgers, Joanna C. Walsh, Ting-Yim Lee, Hon S. Leong, Barbara Fisher
  Abdominal Radiology.2019; 44(11): 3641.     CrossRef
• Pretreatment Blood Biomarkers Predict Pathologic Responses to Neo-Crt in Patients with Locally Advanced Rectal Cancer
  Aijie Li, Kewen He, Dong Guo, Chao Liu, Duoying Wang, Xiangkui Mu, Jinming Yu
  Future Oncology.2019; 15(28): 3233.     CrossRef
• Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis
  Giuseppe N. Fanelli, Fotios Loupakis, Elizabeth Smyth, Marco Scarpa, Sara Lonardi, Salvatore Pucciarelli, Giada Munari, Massimo Rugge, Nicola Valeri, Matteo Fassan
  International Journal of Surgical Pathology.2019; 27(8): 816.     CrossRef
• Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
  Tana Machackova, Vladimir Prochazka, Zdenek Kala, Ondrej Slaby
  Cancers.2019; 11(10): 1545.     CrossRef
• Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy
  Qunsheng Huang, Huabo Qin, Jian Xiao, Xiaosheng He, Minghao Xie, Xin He, Qiuqiong Yao, Ping Lan, Lei Lian
  Gastroenterology Report.2019; 7(4): 283.     CrossRef
• Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma
  M. L. Sánchez de Molina, C. Díaz del Arco, P. Vorwald, D. García-Olmo, L. Estrada, M. J. Fernández-Aceñero
  Clinical and Translational Oncology.2018; 20(2): 253.     CrossRef
• Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy
  Rupert Langer, Karen Becker
  Virchows Archiv.2018; 472(2): 175.     CrossRef
• Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08)
  Roger von Moos, Dieter Koeberle, Sabina Schacher, Stefanie Hayoz, Ralph C. Winterhalder, Arnaud Roth, György Bodoky, Panagiotis Samaras, Martin D. Berger, Daniel Rauch, Piercarlo Saletti, Ludwig Plasswilm, Daniel Zwahlen, Urs R. Meier, Pu Yan, Paola Izzo,
  European Journal of Cancer.2018; 89: 82.     CrossRef
• A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers
  You Guo, Weizhong Jiang, Lu Ao, Kai Song, Huxing Chen, Qingzhou Guan, Qiao Gao, Jun Cheng, Huaping Liu, Xianlong Wang, Guoxian Guan, Zheng Guo
  Radiotherapy and Oncology.2018; 129(1): 149.     CrossRef
• Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings
  Min Ju Kim, Bo Yun Hur, Eun Sun Lee, Boram Park, Jungnam Joo, Min Jung Kim, Sung Chan Park, Ji Yeon Baek, Hee Jin Chang, Dae Yong Kim, Jae Hwan Oh, Ju-Seog Lee
  PLOS ONE.2018; 13(4): e0195815.     CrossRef
• Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer
  J K Jang, J L Lee, S H Park, H J Park, I J Park, J H Kim, S H Choi, J Kim, C S Yu, J C Kim
  British Journal of Surgery.2018; 105(12): 1671.     CrossRef
• Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
  Changhoon Song, Joo-Hyun Chung, Sung-Bum Kang, Duck-Woo Kim, Heung-Kwon Oh, Hye Seung Lee, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jae-Sung Kim
  Cancers.2018; 10(9): 319.     CrossRef
• Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer
  Karina Vychnevskaia, Frederic Dumont, Julie Agostini, Catherine Julié, Peggy Dartigues, Thierry Lazure, Valérie Boige, Diane Goéré, Antoine Brouquet, Christophe Penna, Frédérique Peschaud, Stéphane Benoist
  Annals of Surgical Oncology.2017; 24(5): 1304.     CrossRef
• Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
  Delphine Dayde, Ichidai Tanaka, Rekha Jain, Mei Tai, Ayumu Taguchi
  International Journal of Molecular Sciences.2017; 18(3): 573.     CrossRef
• Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy
  Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Giuliana Pagliani, Elisabetta Mattioli, Valeria Barresi
  Histopathology.2017; 71(3): 393.     CrossRef
• Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer
  Tarkan Jäger, Daniel Neureiter, Romana Urbas, Eckhard Klieser, Wolfgang Hitzl, Klaus Emmanuel, Adam Dinnewitzer
  Diseases of the Colon & Rectum.2017; 60(8): 815.     CrossRef
• Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer
  Dae Kyung Sohn, Kyung Su Han, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Ji Yeon Baek, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Dae Yong Kim
  Surgical Oncology.2017; 26(4): 453.     CrossRef
• Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
  Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Valeria Barresi
  World Journal of Gastroenterology.2017; 23(8): 1412.     CrossRef
• Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
  Ombretta Repetto, Valli De Re, Antonino De Paoli, Claudio Belluco, Lara Alessandrini, Vincenzo Canzonieri, Renato Cannizzaro
  Oncotarget.2017; 8(17): 28328.     CrossRef
• Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers
  You Guo, Jun Cheng, Lu Ao, Xiangyu Li, Qingzhou Guan, Juan Zhang, Haidan Yan, Hao Cai, Qiao Gao, Weizhong Jiang, Zheng Guo
  Scientific Reports.2016;[Epub]     CrossRef
• Analysis of long-term outcomes and application of the tumor regression grading system in the therapeutic assessment of resectable limited-disease small cell lung cancer
  Shuonan Xu, Jianfei Zhu, Yawei Dou, Wei Tian, Yun Dai, Xianghui Luo, Hongtao Wang
  Oncology and Translational Medicine.2016; 2(5): 227.     CrossRef

Citations

Citations to this article as recorded by  

• Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment
  Maria Chiara Sergi, Elisabetta Filoni, Giacomo Triggiano, Gerardo Cazzato, Valeria Internò, Camillo Porta, Marco Tucci
  Current Oncology Reports.2023; 25(11): 1247.     CrossRef
• Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations
  Philipp Jurmeister, Niklas Wrede, Inga Hoffmann, Claudia Vollbrecht, Daniel Heim, Michael Hummel, Peggy Wolkenstein, Ines Koch, Verena Heynol, Wolfgang Daniel Schmitt, Anne Thieme, Daniel Teichmann, Christine Sers, Andreas von Deimling, Julia Cara Thierau
  The Journal of Pathology.2022; 256(1): 61.     CrossRef
• Actionable Mutation Profile of Sun-Protected Melanomas in South America
  Ricardo Hsieh, Marcello M. S. Nico, Cláudia M. C. Camillo, Kátia K. Oliveira, Dirce M. Carraro, Martin Sangueza, Silvia V. Lourenço
  The American Journal of Dermatopathology.2022; 44(10): 741.     CrossRef
• Mucosal melanoma: current strategies and future directions
  Shaheer Khan, Richard D. Carvajal
  Expert Opinion on Orphan Drugs.2019; 7(10): 427.     CrossRef

Citations

Citations to this article as recorded by  

• CAR-T Therapies in Solid Tumors: Opportunities and Challenges
  Grace Guzman, Megan R. Reed, Kevin Bielamowicz, Brian Koss, Analiz Rodriguez
  Current Oncology Reports.2023; 25(5): 479.     CrossRef
• Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population‐based study
  Guo Yuan How, Chik Hong Kuick, Min Hwee Yong, Shui Yen Soh, Esther XY Hee, Meng Kang Wong, Richard Quek, Mohd Farid Harunal, Sathiyamoorthy Selvarajan, Kesavan Sittampalam, Chetan Anil Dhamne, Victor Lee, Kenneth TE Chang, Amos HP Loh
  Asia-Pacific Journal of Clinical Oncology.2023;[Epub]     CrossRef
• Pediatric sarcoma survivorship: A call for a developmental cascades approach
  Peter M. Fantozzi, Gina Sprint, Anna Marie Medina
  Development and Psychopathology.2022; 34(4): 1221.     CrossRef
• Clinical Perspectives for 18F-FDG PET Imaging in Pediatric Oncology: Μetabolic Tumor Volume and Radiomics
  Vassiliki Lyra, Sofia Chatziioannou, Maria Kallergi
  Metabolites.2022; 12(3): 217.     CrossRef
• Desmoplastic Small Round Cell Tumors With EWS-WT1 Transcript Expression: Should We Consider Children and Adult Patients Differently?
  Laura Olivier-Gougenheim, Daniel Orbach, Vincent Atallah, Perrine Marec-Berard, Amandine Bertrand
  Journal of Pediatric Hematology/Oncology.2022; 44(3): e637.     CrossRef
• Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
  Antonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, Vanessa Segura, Yania Yáñez, Bárbara Juan, Marta Salom, Margarita Llavador, Jaime Font de Mora, Victoria Castel, Adela Cañete
  Journal of Personalized Medicine.2021; 11(4): 268.     CrossRef
• Ewing Sarcoma
  Hee Young Ju
  Clinical Pediatric Hematology-Oncology.2019; 26(1): 27.     CrossRef
• Emerging trends in immunotherapy for pediatric sarcomas
  Kyle A. Dyson, Brian D. Stover, Adam Grippin, Hector R. Mendez-Gomez, Joanne Lagmay, Duane A. Mitchell, Elias J. Sayour
  Journal of Hematology & Oncology.2019;[Epub]     CrossRef